ABSTRACT
Restrictive legislation, which is the main barrier to some assisted reproductive technology (ART) services in many countries, is non-existent in Ghana. However, ART services are concentrated in the capital cities of only four out of the sixteen regions, serving predominantly middle- and upper-class individuals. There is limited evidence about the factors preventing broader access to ART services in Ghana, and this study aims to document these barriers. A cross-sectional survey was conducted in July 2024 across all 22 fertility centers in Ghana, using two structured questionnaires administered via Google App to 61 ART personnel and 104 treatment defaulters. Results showed that mentorship from senior colleagues (65.57%) was the most common way for ART professionals to acquire skills. Almost all (91.80%) professionals offered a full range of ART procedures, but 86.89% advocated for regulated practice. They identified high treatment costs (70.49%) and lack of awareness (16.39%) as the most significant barriers. Among treatment defaulters, 88.47% had sought ART services based on word-of-mouth recommendations, compared to only 4.8% influenced by traditional or social media. More than half (50.96%) of the women were in their thirties, and 48.08% required in vitro fertilization (IVF). While 58.65% sought treatment within five years of infertility, 70.2% discontinued due to high costs, and 35.57% due to partner non-availability. Despite the absence of restrictive policies for ART services in Ghana, Prohibitive costs, partner non-availability, and lack of awareness limit access. However, ART professionals expressed the need for regulated practices.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The author(s) received no specific funding for this work.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethical approval for the survey, CHRPE/AP/205/24, was obtained from the Committee on Human Research, Publications, and Ethics (CHRPE) at Kwame Nkrumah University of Science and Technology (KNUST), School of Medical Sciences, Kumasi.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
The data underlying the results presented in the study are available from the corresponding author upon request
